Advertisement.

EXAI Projected Dividend Yield

ADS/Exscientia Plc ( NASDAQ : EXAI )

Exscientia is an artificial intelligence-driven pharmatech company focused discovering, designing and developing drugs. Co.'s lead drug candidate, EXS21546, is Co.'s only internally-developed drug candidate in clinical development. Co. has assessed its clinical stage A2A antagonist, EXS21546, in primary pancreatic and lung cancer tissue samples from patients. Not only could A2A-induced immune suppression be reversed, but the compound also exhibited cancer cell killing activity. Co.'s other two drug candidates, also in clinical trials, are being developed by Co.'s collaboration partner, Sumitomo Dainippon Pharma Co., Ltd.

20 YEAR PERFORMANCE RESULTS

EXAI Dividend History Detail
EXAI Dividend News
EXAI Competitors News

# of Shares: 0

Closing Price: 5.20

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000